In ATB patients, a significant and continuous decline of sBTLA (P = 0.031) level were found after 6-month anti-TB treatment, while sPD-L1 only showed an early decline within 6 months (P = 0.002). This evidence concerns the gene SPDL1 and tuberculosis.